40 likes | 51 Vues
Report from ATOME Meeting in Cyprus. Willem Scholten, PharmD, MPA Team Leader, Access to Controlled Medicines, World Health Organization, Geneva, Switzerland +41 22 79 15540 scholtenw@who.int 30 May, 2012 Societal Impact of Pain 2012, Copenhagen
E N D
Report from ATOME Meeting in Cyprus Willem Scholten, PharmD, MPA Team Leader, Access to Controlled Medicines, World Health Organization, Geneva, Switzerland +41 22 79 15540 scholtenw@who.int 30 May, 2012 Societal Impact of Pain 2012, Copenhagen Directly from The Classic Hotel, Nicosia, Cyprus
Access to Controlled Medicines Programme • WHO Programme since 2007 • All controlled medicines: • Opioid analgesics (e.g. morphine) • Long-acting opioids for treatment of heroin dependence (e.g. methadone) • Other (anti-epileptics, anxyolitics, obstetric medicines) • Small team – volunteers and interns • Beyond October 2012 ?
ATOME • Access to Opioid Medicines in Europe • Consortium of 10 partners • Legislation and policy review for access to opioids • Working with the countries • Now "national conference" to generate critical mass • Reports to MoHs in 2014